Two monocyte-derived cytokines, interleukin-1 (IL-1) and interleukin-6 (IL-6). have been reported to costimulate monocyte-depleted T cell populations in the presence of mitogen, and this effect has been attributed to an accessory function of these molecules. We have now examined further the accessory function potential of IL-1 plus IL-6, and examined how these cytokines promote T cell growth with mitogen. Together, IL-1 and IL-6 additively and, to a small degree, synergistically promote the proliferation of highly purified human peripheral blood T cells with phytohemagglutinin (PHA). However, maximum costimulation by IL-1 plus IL-6 over a wide range of concentrations is significantly smaller than that induced by optimal numbers of monocytes. Also, in contrast to monocytes that costimulate equally effectively T4 positive and T8 positive cells, induces IL-2 secretion in T cell cultures costimulated with PHA, and an antibody to the IL-2 receptor, anti-Tac, markedly inhibits PHA-activated T cells costimulated by IL-1 plus IL-6. In addition, IL-1 plus IL-6 enhances the expression of surface IL-2 receptors. Because the costimulatory effect of IL-1 plus IL-6 is quantitatively smaller than that of monocytes, and it is preferentially directed toward T4 positive as opposed to T8 positive T cells, IL-1 plus IL-6. together, appear to represent a selective set of monocytederived accessory signals. cell costimulation by IL-6, however, was reported to be smaller in magnitude than that induced by optimal numbers of accessory cells and, for the most part, not to be associated with IL-2 production.16-20 Recently, IL-1 and IL-6 have been reported to strongly synergize in the induction of mitogeninduced T cell proliferation."
IL-1 plus IL-6 costimulate T4 positive lymphocytes in marked preference to T8 positive cells. 11-1 plus IL-6 induces IL-2 secretion in T cell cultures costimulated with PHA, and an antibody to the IL-2 receptor, anti-Tac, markedly inhibits PHA-activated T cells costimulated by IL-1 plus IL-6. In addition, IL-1 plus IL-6 enhances the expression of surface IL-2 receptors. Because the costimulatory effect of IL-1 plus IL-6 is quantitatively smaller than that of monocytes, and it is preferentially directed toward T4 positive as opposed to T8 positive T cells, IL-1 plus IL-6. together, appear to represent a selective set of monocytederived accessory signals.
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cell costimulation by IL-6, however, was reported to be smaller in magnitude than that induced by optimal numbers of accessory cells and, for the most part, not to be associated with IL-2 production. [16] [17] [18] [19] [20] Recently, IL-1 and IL-6 have been reported to strongly synergize in the induction of mitogeninduced T cell proliferation."
In the present study, we have examined further the role and mode of action of IL-1 and IL-6 as monocyte-derived accessory signals. The results show that IL-1 and IL-6 additively and, to a small degree, synergistically promote peripheral blood T cell proliferation in response to phytohemagglutinin (PHA). This effect of IL-1 plus IL-6 involves, at least in part, IL-2 production and IL-2 receptor expression. T cell costimulation by IL-1 plus IL-6, however, is significantly smaller in magnitude than that induced by optimal numbers of monocytes. In addition, unlike the monocytes, IL-1 plus IL-6 costimulates T4 cells in marked preference to T8 cells. Thus, IL-1 and IL-6 do not account for all accessory signals required for induction of T cell proliferation, but may prove to be important in the physiologic activation of T4 positive T cells.
MATERIALS AND METHODS

Preparation of cells.
Purified T cells were prepared from mononuclear cells obtained by density centrifugation of normal peripheral blood." Depletion of monocytes from mononuclear cells was obtained by passage over a Sephadex G10 column (Pharmacia Inc, Piscataway, NJ).22 Enrichment for T cells was obtained by rosetting monocyte-depleted mononuclear cells with 2-aminoethyl-isothiouronium bromide-treated (AET) sheep erythrocytes, and separating the rosette-forming cells on a density gradient." The resulting T cell population contained 96% to 98% T cells (cell staining with OKTl1, Ortho Diagnostics, Raritan, NJ), less than 1% B cells (surface Ig positive cells), and less than 1% monocytes (nonspecific esterase positive cells). In selected experiments, these already purified T cell populations were further purified by first staining the cells with a mixture of anti-T4 and anti-TS fluoresceinated antibodies (both from Coulter Immunology, Hialeah, FL), and then sorting the 30% Otsuka Pharmaceutical Co, Tokushima, Japan) had a specific activity of approximately 1 x 10' u/mg protein. One unit of IL-1 is defined as the amount required for half maximal costimulation of mouse thymocytes." Purified, E coli-derived IL-6 (a gift of Drs T. Hirano and T. Kishimoto, Osaka University, Osaka, Japan) had a specific activity of approximately 5 x lo6 U/mg. One unit of IL-6 is defined as the amount required for half-maximal stimulation of IgM production by an indicator Epstein-Barr virus (EBV)-induced lymphoblastoid cell line cultured for 3 days at a cell density of 1 x lo4 cells per 0.2 mL ell.^'.^* Recombinant IL-2 was obtained from Cetus Corp, Emeryville, CA. IL-2 was measured by its ability to support the growth of the IL-2-dependent cell line CTLL, as described previously.29 One unit of IL-2 was defined by comparison with an IL-2 standard preparation (Biologic Response Modifiers BRM standard); one unit of this standard corresponds to approximately 8 units of Cetus IL-2. Culture medium consisted of RPMI 1640 (Biofluids, Rockville, MD) supplemented with 10% heat inactivated fetal calf serum (FCS; Reheis, Armour Pharmaceutical Co, Kankakee, IL), 2 mmol L-glutamine (GIBCO, Grand Island, NY), and 5 pg/mL gentamicin (Sigma). Functional assays were carried out in 96-well Rat bottom plates (Costar, Cambridge, MA) in triplicate, with 200 pL final volume. The plates were incubated at 37OC in a humidified atmosphere containing 5% CO,. DNA synthesis was determined by '[Hlthymidineuptake (0.5 pCi per well, 6.7 Ci/mmol; New England Nuclear, Boston, MA) during the last 4.5 to 24 hours of culture.
Synergy of T cell costimulation by IL-1 and IL-6 in the presence of PHA was determined according to the formula: Reagents, MoAbs. cytokines. and cytokine bioassays.
Cell cultures and assays for T cell proliferation.
A synergy value of 1 indicates that IL-1 and IL-6 are additive in their effects; a synergy value greater than 1 indicates that IL-1 and IL-6 are synergistic.
Purified T cells were cultured in 24-well Linbro tissue culture plates (Flow Labs, McLean, VA) at a cell density of 1 x lo6 cells/mL, either in medium alone or with PHA (0.2 pg/mL). After 24 and 48 hours, the cells were washed, resuspended a t 10 x lo6 cells/mL in PBS containing 5% FCS, and incubated for 30 minutes at 4OC with a fluorescein-labeled antibody to the IL-2 receptor (Becton Dickinson) and control reagents. The cells were then washed, resuspended in PBS containing 1% paraformaldehyde, and analyzed on a FACScan (Becton Dickinson). For each determination, 1 x lo4 cells were examined.
Determination of ZL-2 receptor expression.
RESULTS
IL-lp and IL-6 enhance T cell proliferation to PHA. To elucidate the activity of IL-I and IL-6 on T lymphocytes, T cells were purified from peripheral blood mononuclear cells by a three-step procedure that included sequential removal of monocytes by passage of mononuclear cells through a Sephadex G10 column, selection of cells rosetting with sheep erythrocytes sensitized with AET, and sorting the 30% most fluorescent small cells after staining with a mixture of fluorescein-labeled antibodies to T4 and T8. The resulting T cell population contained greater than 99% T4 and T8 positive cells and less than 0.1% nonspecific esterase staining cells. As shown in a representative experiment (Fig l) ually to these T cells in the presence of PHA (0.75 pg/mL), IL-1 and IL-6 caused a 2-and 13-fold increase in DNA synthesis, respectively. Thus, under the conditions used, IL-1 and IL-6 enhanced at least additively and, to a small degree, synergistically (synergy value 1.8), T-cell proliferation to PHA. It should be noted that irradiated monocytes (2 x lo4 per well) induced much greater T-cell responses to PHA than those elicited by IL-1 plus IL-6. Because the T cells used in these experiments were highly purified, these results further suggest that IL-1 and IL-6 act directly on T cells, and not on an intermediate cell target.
As shown in Fig 1, IL-1 plus IL-6 promoted T-cell proliferation in response to PHA, but, under the conditions used, this costimulatory effect was significantly smaller in magnitude than that induced by optimal numbers of accessory cells. We wished to establish what the maximal effect of costimulation by IL-1 plus IL-6 might be, and how this compared with that achieved by accessory cells. To gain this information, we first determined the response curves of T cells to costimulation with either IL-1 or IL-6 added individually in culture. As shown in a representative experiment of four performed (Fig 2) , IL-1 alone increased the proliferation of PHA-activated T cells by a maximum of approximately twofold at a dose of 1 to 100 ng/mL (A); IL-6 alone increased the proliferation of PHA-activated T cells by a maximum of approximately 3.5-fold at a dose of 10 to 1,000 U/mL (B). We then used IL-1 and IL-6 together at varying concentrations. Using both cytokines together at optimal or superoptimal concentrations (Fig 2C and D) , T-cell proliferation in response to PHA was increased by a maximum of sevenfold. When used together at suboptimal concentrations (IL-1 at 0.5 ng/mL and IL-6 at 5 U/mL), these cytokines increased T-cell proliferation to PHA by approximately fivefold (synergy value 2.7; Fig 3) . In all experiments (Figs $ "t" 2D and 3), irradiated monocytes at optimal concentrations induced much greater T-cell proliferative responses to PHA than IL-1 plus IL-6. Together, these experiments indicate that neither IL-1 nor IL-6 individually, even at high concentrations, is as effective as the two molecules added together in promoting T-cell growth. Over a wide range of concentrations, IL-1 and IL-6 act additively and somewhat synergistically in promoting T-cell growth in response to PHA. However, the maximum level of T cell costimulation induced by IL-1 plus IL-6 is always significantly lower than that achieved in parallel cultures supplemented with monocytes. These findings demonstrate that full replacement of accessory signals provided by monocytes is not achieved by 1L-1 together with IL-6. T cell subset responsiveness to costimulation by IL-1 and IL-6. To obtain further insight in the process of T-cell costimulation by IL-1 plus IL-6, monocyte-depleted T cells were further purified into subsets enriched for T8-expressing and T4-expressing markers. As shown in Table 1 , the T4-positive T-cell subset responded better to costimulation by IL-1 plus IL-6 (a mean of 16.2-fold) when compared with the TI-positive T-cell subset (a mean of 6.2-fold). In contrast, both T-cell populations responded equally well to PHA when irradiated mononuclear cells were added as a source of accessory cells. Also, both T-cell subsets responded fairly equally to either IL-1 or IL-6 added individually in the presence of PHA. Thus, the greater response to IL-1 plus IL-6 by T4-positive T cells as opposed to T8-positive T cells was attributable to a greater degree of cytokine synergy occurring in this T-cell subset (synergy values for TCpositive and T8-positive cells were 4.0 and 0.9, respectively). It should be noted that, in these experiments, unfractionated T cells and recombined TCpositive and T8-positive cells (3: 1 ratio) revealed a slightly different degree of IL-1 and IL-6 synergy (1 .O versus 2.8); this difference might be due, at least in part, to the different T-cell subset composition of the two responder populations. The preferential responsiveness to IL-1 plus IL-6 of T4-positive as opposed to T8-positive cells was observed over a wide range of cytokine concentrations (Fig 4) , and thus was not a dose-related phenomenon.
Together, these findings demonstrate that T-cell costimulation of T cells by IL-1 plus IL-6 is preferentially directed toward T4-positive T cells.
Time requirements of IL-1 and IL-6 addition to culture. We tested the time requirements of IL-1 and IL-6 addition to culture for induction of T-cell costimulation with PHA. In particular, we asked whether either IL-1 or IL-6 would prepare the cells to respond or prevent the cells from responding to both cytokines present in secondary cultures. To this end, purified T cells were cultured for 24 hours in medium, PHA, PHA plus IL-I, PHA plus IL-6, or PHA plus IL-1 and IL-6, and then exposed to appropriate secondary stimulations. A representative experiment of four performed is shown in Table 2 . If the cultures were incubated for a total of 72 hours, best T-cell costimulation was observed when both IL-1 and IL-6 were present from the outset of culture (9.2-fold increment of the response induced by PHA alone; synergy value 2.0). The lowest degree of costimulation at 72 hours (4.2-fold), and no synergy (synergy value 0.8) were observed when IL-1 and IL-6 were both added after a 24-hour T-cells preculture. Intermediate and comparable degrees of costimulation at 72 hours (6.1-fold in each case) and synergy (synergy values 1.3 and 1.2) were observed when either IL-1 or IL-6 was present during primary cultures with PHA, and the other cytokine was added in secondary cultures. This finding suggests that either IL-1 or IL-6, individually, can initiate a T cell response that contributes to the ultimate response. This is further supported by the observation that by 96 hours in culture, T cells proliferated fairly equally to IL-1 and IL-6 in secondary cultures, whether both or only one of the cytokines were present in primary culture with PHA (increments of T cell response to PHA ranged between 5.5 and 5.9; synergy factors ranged between 1.4 and 1.5). In contrast, if addition of both IL-1 and IL-6 was delayed by 96 hours in culture, there was little costimulation by the cytokines (three-fold), and there was no synergism (synergy factor 0.6). Thus, optimal costimulation by IL-1 plus IL-6 requires that at least one of the cytokines be present during the first 24 hours of culture.
TOSATO ET AL
Production of IL-2 in T-cell cultures costimulated with IL-1 plus IL-6. To ascertain whether T-cell proliferation induced by IL-1 plus IL-6 is mediated via stimulation of IL-2 production by T cells, we added an anti-IL-2 receptor MoAb. The antibody used, anti-Tac, recognizes p55, a peptide that in association with p75, is believed to constitute the high affinity receptor for IL-2; anti-Tac blocks IL-2-induced T-cell proliferation mediated through the high affinity IL-2 receptor.3D32 As shown in Fig 5A, IL-1 enhanced T-cell proliferation to PHA in a dose-dependent manner, and this growth-promoting effect of IL-1 was markedly inhibited by the addition of anti-Tac (mean inhibition greater than 80%). In contrast, anti-Tac inhibited only minimally T-cell proliferation in the presence of IL-6 when added at concentrations ranging between 0.1 and 100 U/mL (mean inhibition 36%; Fig 5B) . These findings suggest that while IL-1-induced T-cell costimulation is largely IL-2 mediated, IL-6-induced T-cell costimulation is not. The effects of anti-Tac on T-cell costimulation by IL-1 plus IL-6 are shown in Fig 5C. As shown, the enhanced T-cell proliferation caused by IL-1 plus IL-6 was significantly inhibited by anti-Tac (mean inhibition greater than 70%). This finding suggests that T-cell costimulation by IL-1 plus IL-6 is attributable, at least in part, to stimulation of IL-2 production.
It is unlikely that the incomplete inhibition of IL-1 plus IL-6 costimulation by anti-Tac is due to insufficient antibody, because higher concentrations (up to 80 pg/mL) failed to yield greater levels of inhibition. Furthermore, in parallel control experiments, anti-Tac inhibited by greater than 90% the high level T-cell proliferation induced by exogenously added IL-2 (1.5 to 48 U/mL; Fig 6A) . It is worth noting, however, that anti-Tac inhibited by a mean of only 68.3% T-cell proliferation to PHA in the presence of added monocytes (Fig 6B) .
It is possible that a T-cell growth factor or factors other than IL-2 are also induced in these cultures, and that production of these additional T-cell growth factors is responsible for the incomplete neutralization by anti-Tac. If so, IL-4 does not appear to be involved, because T-cell responses induced by IL-6 plus PHA alone or with IL-1 were not inhibited, even minimally, by a neutralizing heteroantiserum to IL-4; in parallel experiments, this antiserum inhibited T-cell responses to exogenous IL-4 (not shown).
To more directly assess whether IL-2 is coinduced by IL-1 plus IL-6, we tested for the presence of IL-2 in these cultures. To reduce IL-2 consumption and increase the sensitivity of the assay, we have added anti-Tac (5 pg/mL) to the T-cell cultures, as previously de~cribed.'~ Also, to ensure specificity, we established that the indicator cell line used, CTLL, was not responsive to exogenous human IL-4 over a wide range of concentrations (not shown). As shown (Table 3) , IL-1 plus IL-6 consistently induced the release of IL-2 in T-cell cultures costimulated with PHA; the mean amount of IL-2 induced (0.88 U/mL) was much greater (17.6-fold) than that induced in T-cell cultures stimulated with PHA alone. When added individually to PHA-stimulated cultures, IL-1 and IL-6 induced low level (0.11 U/mL and 0.01 U/mL, respectively) IL-2 release above background (0.05 U/mL); when added together, IL-1 and IL-6 induced the release of much greater amounts of IL-2 than that induced by the two individually, indicating IL-1 and IL-6 synergy (synergy value 6.9). This finding confirms that IL-1 plus IL-6 coinduce the release of IL-2, and this T-cell growth factor may be responsible, at least in part, for enhanced T-cell proliferation induced by these cytokines.
Lastly, we examined the effect of IL-I plus IL-6 on IL-2 receptor expression. As shown in Table 4 , IL-1 plus IL-6 enhanced IL-2 receptor expression on PHA-activated T cells, as reflected by the increased mean fluorescence intensity detected on these cells exposed to a fluoresceinated antibody to the IL-2 receptor. This effect was more clearly appreciated at 24 hours, at which time the effects of IL-1 plus IL-6 on 
DISCUSSION
Many studies have focused on the elucidation of the accessory signals required for T-cell proliferation in response to mitogen, or antigen. IL-1 and, more recently, IL-6 have been reported to function as accessory signals, but neither alone was found to account for all accessory cell functions Our studies show that IL-1 and IL-6 additively and, to a small degree, synergistically promote the growth of normal peripheral blood T cells costimulated with PHA. This costimulatory effect of IL-1 and IL-6 is significantly smaller in magnitude than that induced by optimal numbers of monocytes in the presence of PHA, suggesting that accessory signals by monocytes involve more than IL-1 and IL-6 combined.
When unfractionated T cells were used, the degree of synergy between IL-1 and IL-6 was found to range between none (only an additive effect) and modest. Previous studies of mitogen-induced T-cell Proliferation have reported a variable degree of synergy by IL-1 and IL-6; one study, consistent with our own, reported only modest synergy,20 while another reported strong synergy.17 It is unlikely that the lower degree of IL-1 and I€,-6 synergy in our study can be attributed to insufficient amounts of these cytokines being added to the cultures, because saturating responses were achieved. It is also unlikely that a relative unresponsiveness of the target T cells might account for our results, because in each experiment the T cells showed a brisk proliferative response to monocyte costimulation. A possible reason for the strong synergy observed in one study might be that it used tonsillar rather than peripheral blood T lymphocytes used in the other studies. Regardless of what the maximum level of IL-1 and IL-6 synergy might be, a comparison between IL-1 plus IL-6 and monocytes shows that accessory signals provided by optimal numbers of monocytes are much more effective in inducing peripheral blood T-cell proliferation than those elicited by saturating amounts of IL-1 plus IL-6. subset, Thl, produces IL-2 and IFN, and uses only IL-2 as its autocrine growth factor; the other subset, Th2, secretes IL-4 and uses IL-4 as its autocrine growth factor. Th2 cells are selectively induced by IL-1 to produce IL-4.9 It is possible that human T cells may also be composed of subsets distinguished on the basis of patterns of autocrine growth factor production. These T-cell subsets could also differ on the basis of patterns of responsiveness to accessory signals inducing these autocrine growth factors, and the data presented here support this hypothesis.
There are additional explanations for the failure of IL-1 together with IL-6 to costimulate T cells as effectively as accessory cells. It is possible that full replacement of accessory functions requires the presence of a number of cytokines, perhaps including IL-1 and IL-6. In this regard, a recent study has reported on a monocyte-derived cytokine, distinct from IL-1 and IL-6, that induces IL-2 receptor expre~sion.~~ It is possible that, in addition to cytokines in solution, membrane-associated molecules are required. Perhaps the relative concentrations of a group of cytokines, and the fine timing of their release may explain some of the subtleties of T-cell triggering.
We have examined in detail the mechanism of T-cell costimulation by IL-1 plus IL-6, and found that IL-2 is likely to be involved, at least in part, in these processes. IL-2 can be detected in the culture supernatants of IL-1 plus IL-6 costimulated T cells in significantly greater amounts than those found in otherwise identical cultures not containing these cytokines. Also, an antibody to the IL-2 receptor, anti-Tac, markedly inhibits T-cell proliferation induced by IL-1 plus IL-6 in the presence of mitogen, This indicates that IL-2 not only is produced in culture but also is required for the enhanced proliferation induced by IL-1 plus IL-6. Finally, IL-2 receptor expression on mitogen-costimulated T cells is enhanced by IL-1 plus IL-6.
It is possible that autocrine growth factors other than IL-2 may also be induced by IL-1 plus IL-6. This is supported by the observation that IL-6, when added alone to PHAactivated T cells, promotes their proliferation without inducing significant IL-2 production or IL-2 receptor expression. 16 Also, addition of an anti-IL-2 receptor MoAb resulted in significant, but incomplete, neutralization of T-cell proliferation caused by IL-1 plus IL-6, suggesting that, in the presence of IL-1, IL-6 still induces a growth factor distinct from IL-2. We have addressed the possibility that IL-4 is induced by either IL-6 alone or with IL-1. However, the addition of a neutralizing antiserum to human IL-4 failed to even minimally affect the enhanced T-cell proliferation caused by IL-6 alone or together with IL-1. It should be noted, in this respect, that recent studies have suggested the existence of T-cell growth factors in addition to IL-2 and IL-4.5 Much needs to be learned about accessory signal requirements for T-cell proliferation. The studies presented here show that IL-1 and IL-6 can provide accessory signals to PHA-costimulated T cells, and do so, at least in part, by promoting IL-2 secretion. However, IL-1 plus IL-6 is significantly less effective than monocytes in providing accessory signals to mitogen-costimulated T cells, and appears to preferentially involve T4-positive T cells. Identification of other cytokines and dissection of their relative effects on T-cell proliferation may aid in further understanding T-cell triggering.
